Cleared Traditional

K242685 - Atellica® CH Creatinine_3 (Crea3) (FDA 510(k) Clearance)

Dec 2024
Decision
89d
Days
Class 2
Risk

K242685 is an FDA 510(k) clearance for the Atellica® CH Creatinine_3 (Crea3). This device is classified as a Alkaline Picrate, Colorimetry, Creatinine (Class II - Special Controls, product code CGX).

Submitted by Siemens Healthcare Diagnostics, Inc. (Tarrytown, US). The FDA issued a Cleared decision on December 4, 2024, 89 days after receiving the submission on September 6, 2024.

This device falls under the Chemistry FDA review panel. Regulated under 21 CFR 862.1225.

Submission Details

510(k) Number K242685 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 06, 2024
Decision Date December 04, 2024
Days to Decision 89 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF

Device Classification

Product Code CGX — Alkaline Picrate, Colorimetry, Creatinine
Device Class Class II - Special Controls
CFR Regulation 21 CFR 862.1225